25 research outputs found
Recommended from our members
Genome Elimination Mediated by Gene Expression from a Selfish Chromosome
Numerous plants and animals harbor selfish B chromosomes that âdriveâ or transmit themselves at super-Mendelian frequencies, despite long-term fitness costs to the organism. Currently, it is unknown how B chromosome drive is mediated, and whether B-gene expression plays a role. We used modern sequencing technologies to analyze the fine-scale sequence composition and expression of paternal sex ratio (PSR), a B chromosome in the jewel wasp Nasonia vitripennis. PSR causes female-to-male conversion by destroying the spermâs hereditary material in young embryos to drive. Using RNA interference, we demonstrate that testis-specific expression of a PSR-linked gene, named haploidizer, facilitates this genome eliminationâandâsex conversion effect. haploidizer encodes a putative protein with a DNA binding domain, suggesting a functional link with the sperm-derived chromatin
Synthesis and Characterization of Ag/PEDOT:PSS Films Used for NH Selective Sensing
Nano-Ag/PEDOT-PSS films were prepared by spin-coating technique. SEM surface morphology, Raman spectra and gas sensing of methanol, humidity and NH3 were studied. The obtained results showed that the resistance of Ag/PEDOT:PSS sheets exposed to gases related to the generation of electrons from the gases adsorption that eliminated holes as the major carriers in PEDOT:PSS. For NH3 gas the largest change of the resistance of Ag/PEDOT:PSS was observed. The less sensitivity of humidity and ethanol sensing was explained due to less dedoping reaction between H2O and ethanol vapor with Ag/PEDOT:PSS, respectively. This suggests a potential application of the nano-Ag/PEDOT-PSS sensors for  the selective monitoring NH3 gas in environment
Investigation of Thermal Annealing Condition on the Optical and Electrical Properties of Hybrid Silver Nanowires/Reduced Graphene Oxide (AgNWS/rGO) Films
Herein we report a electrode in the hybrid  structure of the silver nanowires (AgNWs) with reduced graphene oxide (rGO) deposited on glass or PET substrate. The assembly and contacting in procedures of this hybrid film have been strongly affected by preparation conditions, especially annealing temperature. In this work, we have investigated the effects of thermal annealing on interconnected at nanowire junctions and between AgNWS network and rGO films via their sheet resistance and transmission. The annealing temperature was varied from 120C to 180C with 10C step to find out optimal temperature at which the wires can be joined together. The results show that at 170C, the sheet resistance and transmission of the hybrid rGO/Ag NW film are sq and % (at wavelength 550 nm) corresponding to the ratio of direct conductivity to optical conductivity which is the best obtained value. It is expected that the hybrid AgNWS/rGO film can replace ITO film in the near future
Development of a highly sensitive pointâofâcare test for African swine fever that combines EZâFast DNA extraction with LAMP detection: Evaluation using naturally infected swine whole blood samples from Vietnam
[Background] While early detection and early containment are key to controlling the African swine fever (ASF) pandemic, the lack of practical testing methods for use in the field are a major barrier to achieving this feat. [Objectives] To describe the development of a rapid and sensitive point-of-care test (POCT) for ASF, and its evaluation using swine whole blood samples for field settings. [Methods] In total, 89 swine whole blood samples were collected from Vietnamese swine farms and were performed the POCT using a combination of crude DNA extraction and LAMP (loop-mediated isothermal amplification) amplification. [Results] The POCT enabled crude DNA to be extracted from swine whole blood samples within 10 min at extremely low cost and with relative ease. The entire POCT required a maximum of 50 min from the beginning of DNA extraction to final judgment. Compared to a conventional real-time PCR detection, the POCT showed a 1 log reduction in detection sensitivity, but comparable diagnostic sensitivity of 100% (56/56) and diagnostic specificity of 100% (33/33). The POCT was quicker and easier to perform and did not require special equipment. [Conclusions] This POCT is expected to facilitate early diagnosis and containment of ASF invasion into both regions in which it is endemic and eradicated
Effect of Silver Nanowire Dimension to Ammonia Adsorption of Graphene-silver Nanowires Hybrid
In this report, we study the effect of silver nanowires (AgNws) dimension to electrical properties of rGO/AgNws hybrid. The alteration of these electrical properties leads the difference of ammonia sensibility of the rGO/AgNws hybrid based sensing devices. When the rGO is accompanied by AgNws of different sizes from \sim 500$~\text{nm to } 10\;\mum, the ammonia sensitivity of these hybrids change from 60% to 340% alteration compared with the bare rGO material
Characterization of Ag-Doped p-Type SnO Thin Films Prepared by DC Magnetron Sputtering
Crystalline structure and optoelectrical properties of silver-doped tin monoxide thin films with different dopant concentrations prepared by DC magnetron sputtering are investigated. The X-ray diffraction patterns reveal that the tetragonal SnO phase exhibits preferred orientations along (101) and (110) planes. Our results indicate that replacing Sn2+ in the SnO lattice with Ag+ ions produces smaller-sized crystallites, which may lead to enhanced carrier scattering at grain boundaries. This causes a deterioration in the carrier mobility, even though the carrier concentration improves by two orders of magnitude due to doping. In addition, the Ag-doped SnO thin films show a p-type semiconductor behavior, with a direct optical gap and decreasing transmittance with increasing Ag dopant concentration
Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial
Background
Trials of fluoxetine for recovery after stroke report conflicting results. The Assessment oF FluoxetINe In sTroke recoverY (AFFINITY) trial aimed to show if daily oral fluoxetine for 6 months after stroke improves functional outcome in an ethnically diverse population.
Methods
AFFINITY was a randomised, parallel-group, double-blind, placebo-controlled trial done in 43 hospital stroke units in Australia (n=29), New Zealand (four), and Vietnam (ten). Eligible patients were adults (aged â„18 years) with a clinical diagnosis of acute stroke in the previous 2â15 days, brain imaging consistent with ischaemic or haemorrhagic stroke, and a persisting neurological deficit that produced a modified Rankin Scale (mRS) score of 1 or more. Patients were randomly assigned 1:1 via a web-based system using a minimisation algorithm to once daily, oral fluoxetine 20 mg capsules or matching placebo for 6 months. Patients, carers, investigators, and outcome assessors were masked to the treatment allocation. The primary outcome was functional status, measured by the mRS, at 6 months. The primary analysis was an ordinal logistic regression of the mRS at 6 months, adjusted for minimisation variables. Primary and safety analyses were done according to the patient's treatment allocation. The trial is registered with the Australian New Zealand Clinical Trials Registry, ACTRN12611000774921.
Findings
Between Jan 11, 2013, and June 30, 2019, 1280 patients were recruited in Australia (n=532), New Zealand (n=42), and Vietnam (n=706), of whom 642 were randomly assigned to fluoxetine and 638 were randomly assigned to placebo. Mean duration of trial treatment was 167 days (SD 48·1). At 6 months, mRS data were available in 624 (97%) patients in the fluoxetine group and 632 (99%) in the placebo group. The distribution of mRS categories was similar in the fluoxetine and placebo groups (adjusted common odds ratio 0·94, 95% CI 0·76â1·15; p=0·53). Compared with patients in the placebo group, patients in the fluoxetine group had more falls (20 [3%] vs seven [1%]; p=0·018), bone fractures (19 [3%] vs six [1%]; p=0·014), and epileptic seizures (ten [2%] vs two [<1%]; p=0·038) at 6 months.
Interpretation
Oral fluoxetine 20 mg daily for 6 months after acute stroke did not improve functional outcome and increased the risk of falls, bone fractures, and epileptic seizures. These results do not support the use of fluoxetine to improve functional outcome after stroke